Grainne Quinn - 05 Mar 2024 Form 4 Insider Report for PERRIGO Co plc (PRGO)

Role
EVP, Chief Medical Officer
Signature
/s/ Victor Torres, attorney-in-fact for Ms. Grainne Quinn
Issuer symbol
PRGO
Transactions as of
05 Mar 2024
Transactions value $
$138,808
Form type
4
Filing time
07 Mar 2024, 21:00:41 UTC
Previous filing
08 Mar 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRGO Ordinary Shares Options Exercise $43.2K +1.58K +11.26% $27.26 15.6K 05 Mar 2024 Direct
transaction PRGO Ordinary Shares Tax liability -$22.5K -824 -5.27% $27.26 14.8K 05 Mar 2024 Direct
transaction PRGO Ordinary Shares Award $246K +9.03K +60.91% $27.26 23.9K 05 Mar 2024 Direct
transaction PRGO Ordinary Shares Tax liability -$128K -4.7K -19.69% $27.26 19.2K 05 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRGO Restricted Stock Units Options Exercise -1.58K -100% 0 05 Mar 2024 Ordinary Shares 1.58K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
F2 Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.